Dr. Robert Lanza Receives 2006 'All Star' Award for Biotechnology Oct 24 2006, 9:30 AM EST BIOWIRE
One of the world's leading authorities on embryonic stem cells, Robert Lanza, M.D., VP, Research and Scientific Development for Advanced Cell Technology, Inc. (OTCBB: ACTC) will be honored at the 11th Annual Mass High Tech All-Star Awards Networking Reception, October 25th from 6:00-8:30pm at the Westin Boston Waterfront Hotel.
Robert Lanza, M.D., has over 30 years of medical research experience, and has authored/edited 18 books, including "Essentials of Stem Cell Biology" and the "Handbook of Stem Cells" (as Editor-in-Chief). Last month, Dr. Lanza served as senior author for a paper that appeared in the journal Cloning and Stem Cells, in which ACTC scientists and their collaborators rescued visual function in animals using retinal pigment epithelial cells (RPE) derived from human embryonic stem (hES) cells. In August, Dr. Lanza served as senior author of a paper in Nature, describing a method for deriving stem cells using a single-cell approach that does not harm embryos.
He is a former Fulbright Scholar, and studied as a student in the laboratory of Jonas Salk (The Salk Institute), Richard Hynes (MIT), and Nobel laureates Gerald Edelman (Rockefeller University) and Rodney Porter (Oxford University). He also worked closely (and coauthored a series of papers) with the late Harvard psychologist B.F. Skinner and heart transplant pioneer Christiaan Barnard. Dr. Lanza received his undergraduate and medical degrees from the University of Pennsylvania, where he was both a University Scholar and Benjamin Franklin Scholar.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.